Findings expand Telomir-1's oncology profile into cancers of the blood, adding to previously reported activity in ...

A groundbreaking new study has found that a combination of two drugs can boost survival rates in prostate cancer patients by ...

New hope for advanced prostate cancer patients, with promising new drug combo that targets genes, such as BRCA1, BRCA2, CHEK2 ...

His PSA level was 16 ng/mL, higher than the normal limit of 4.0 ng/mL, indicating the presence of tumour. Not only that, it was aggressive, with a high chance of mortality. However, a novel therapy, ...

A groundbreaking study reveals that combining two drugs significantly boosts survival for men with high-risk, recurring ...

Sansum Clinic and Ridley-Tree Cancer Center will share a panel discussion that was presented on prostate health. To view the video presentation, click ...

New prostate cancer research from an international team led by the Center for Genetic Epidemiology at the Keck School of Medicine of USC has yielded discoveries that could improve screening and ...

Dr. Kurt N. Ransohoff, President, Sutter Health Greater Central Coast, moderated the multidisciplinary panel of six ...

Findings could improve screening and treatment for patients of African ancestry HEALTH REPORT | THE INDEPENDENT & AGENCIES | ...

Investing.com -- Telomir Pharmaceuticals Inc (NASDAQ:TELO) stock jumped 7.9% in premarket trading Friday after the company announced new laboratory findings showing its investigational compound ...